Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives

被引:21
|
作者
Cottin, Vincent [1 ,2 ,3 ]
Martinez, Fernando J. [4 ]
Smith, Vanessa [5 ,6 ,7 ,8 ]
Walsh, Simon L. F. [9 ]
机构
[1] Hosp Civils Lyon, Louis Pradel Hosp, Reference Ctr Rare Pulm Dis, Lyon, France
[2] Claude Bernard Univ Lyon 1, INRAE, UMR754, OrphaLung,RespiFil,Rad ILD, Lyon, France
[3] Claude Bernard Univ Lyon 1, ERN LUNG, Lyon, France
[4] Cornell Univ, Dept Med, New York, NY 10021 USA
[5] Ghent Univ Hosp, Dept Rheumatol, Dept Internal Med, Ghent, Belgium
[6] Univ Ghent, Dept Internal Med, Ghent, Belgium
[7] VIB Inflammat Res Ctr IRC, Unit Mol Immunol & Inflammat, Ghent, Belgium
[8] ERN ReCONNET Rare Connect Tissue Dis, Ghent, Belgium
[9] Imperial Coll London, Natl Heart & Lung Inst, London, England
来源
EUROPEAN RESPIRATORY REVIEW | 2022年 / 31卷 / 165期
关键词
IDIOPATHIC PULMONARY-FIBROSIS; THORACIC SOCIETY; DOUBLE-BLIND; UNMET NEEDS; DIAGNOSIS; MANAGEMENT; PNEUMONIA; WORKING; PIRFENIDONE; PREDICTORS;
D O I
10.1183/16000617.0003-2022
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Multidisciplinary team (MDT) meetings, involving the integrated collaboration of healthcare professionals, are increasingly used in clinical practice to inform the diagnosis and treatment of interstitial lung diseases (ILDs). Over time, the assessment of patients with ILD has transitioned from discussions among clinicians, radiologists and pathologists to the inclusion of a broader range of clinical data and specialist expertise. Studies have shown that a multidisciplinary approach can have many benefits for the clinical care of patients with ILD by improving the diagnostic confidence for different ILDs and guiding treatment decisions. The utility of MDT discussions for diagnosis, monitoring disease progression and management decisions, will need to be considered based on how it is best positioned in the diagnostic and therapeutic process, as well as the practicality and challenges of its use. There are also uncertainties and heterogeneity concerning the optimal practices of MDT meetings in ILD care. In this review, we describe recent developments refining the approach to MDTs in clinical practice, including who should be involved in the MDTs, when it is most needed, their use in patient management, challenges in their implementation, and ongoing controversies in the field that need further research.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Moderate resting hypoxaemia in fibrotic interstitial lung disease
    Khor, Yet H.
    Harrison, Amelia
    Robinson, Julien
    Goh, Nicole S. L.
    Glaspole, Ian
    McDonald, Christine F.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (01)
  • [32] The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases
    Ageely, Ghofran
    Souza, Carolina
    De Boer, Kaissa
    Zahra, Saly
    Gomes, Marcio
    Voduc, Nha
    CANADIAN RESPIRATORY JOURNAL, 2020, 2020
  • [33] Interstitial Lung Disease 2021 2 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
    Spagnolo, Paolo
    Ryerson, Christopher J.
    Putman, Rachel
    Oldham, Justin
    Salisbury, Margaret
    Sverzellati, Nicola
    Valenzuela, Claudia
    Guler, Sabina
    Jones, Steve
    Wijsenbeek, Marlies
    Cottin, Vincent
    LANCET RESPIRATORY MEDICINE, 2021, 9 (09): : 1065 - 1076
  • [34] Workplace Productivity in Patients with Fibrotic Interstitial Lung Disease
    Algamdi, M.
    Sadatsafavi, M.
    Fisher, J. H.
    Morisset, J.
    Johannson, K. A. M.
    Fell, C. D.
    Kolb, M.
    Manganas, H.
    Cox, G.
    Gershon, A. S.
    Halayko, A. J.
    Hambly, N.
    Shapera, S.
    To, T.
    Khalil, N.
    Wilcox, P. G.
    Ryerson, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [35] Significance of Cysts in the Diagnosis of Fibrotic Interstitial Lung Disease
    Minuk, L.
    Hague, C.
    Muller, N.
    Murphy, D.
    Churg, A. M.
    Wright, J. L.
    Al-Arnawoot, A.
    Bilawich, A.
    Bourgouin, P.
    Cox, G. P.
    Durand, C.
    Elliot, T.
    Ellis, J.
    Fisher, J. H.
    Fladeland, D.
    Grant-Orser, A.
    Goobie, G. C.
    Guenther, Z.
    Haider, E.
    Hambly, N.
    Huynh, J.
    Johannson, K. A.
    Karjala, G.
    Khalil, N.
    Kolb, M. R.
    Leipsic, J.
    Lok, S. D.
    Macisaac, S.
    McInnis, M.
    Manganas, H.
    Marcoux, V.
    Mayo, J.
    Morisset, J.
    Scallan, C. J.
    Sedlic, T.
    Shapera, S.
    Sun, K.
    Tan, V.
    Wong, A. W.
    Zheng, B.
    Ryerson, C. J.
    Marinescu, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [36] A Crystal Ball for Hypoxia in Fibrotic Interstitial Lung Disease
    Sood, Shweta
    Kim, John S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (12) : 1705 - 1706
  • [37] Cough in Fibrotic Interstitial Lung Disease: Effects and Implications
    Channick, Jessica E.
    Swigris, Jeff
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (08) : 975 - 976
  • [38] Prevalence And Predictors Of Sarcopenia In Fibrotic Interstitial Lung Disease
    Guler, S. A.
    Lear, S. A.
    Hur, S.
    Camp, P. G.
    Ryerson, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [39] Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease
    Adegunsoye, Ayodeji
    Vij, Rekha
    Noth, Imre
    CHEST, 2019, 155 (05) : 1026 - 1040
  • [40] Oscillometry and Spirometry in Fibrotic Versus Non-fibrotic Interstitial Lung Disease
    Gabrysz-Forget, F.
    Duran, O.
    Azuelos, I.
    Cormier, M.
    Hantos, Z.
    Dandurand, R. J.
    Assayag, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207